OGEN
AMEX
$0.54
Oragenics Inc (OGEN)
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Target: $2 (+270.37%)
Market Cap
$2.45M
P/B Ratio
0.42
Price Chart
Valuation
Market Cap$2.45M
P/S89.28
P/B0.42
Profitability
Gross Profit (TTM)-$2.70M
EBITDA-$9.40M
EPS-$2.19
Growth & Risk
FCF 5Y CAGR-11.58%
Sharpe Ratio-1.09